Purchase Order 75N95023P00818

Award Date 9/14/23
Potential Completion Date 9/13/24
Potential Value $669K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $110,200.00 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency within the U.S. Department of Health and Human Services. The contract is for a service and maintenance agreement for an Axion Biosystems instrument, which is likely one of the company's proprietary Maestro multi-electrode array (MEA) systems or related cell analysis platforms. Axion Biosystems, Inc. is the prime contractor, and the contract...
The Department of Health and Human Services' National Institutes of Health's National Institute of Environmental Health Sciences awarded a $25,000 firm fixed price purchase order to Axion Biosystems, Inc.'s Axion Biosystems Division. Under the contract, Axion will provide its MAESTRO PRO 768 PERFORMANCE ASSURANCE SERVICE PLAN WITH PREVENTIVE MAINTENANCE for use in research being conducted at the prime contractor's facilities in Research Triangle Park, North Carolina. The period of performance is...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The $149,750.00 contract is for the delivery of Lumos multiwell consumable plates to be used with Axion's proprietary Maestro multi-electrode array (MEA) system, which supports biomedical and drug development research...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services (HHS). The contract, valued at $12,960.00, is for the delivery of CYTOVIEW MEA 48-WELL WHITE PLATE (BOX OF 5) by the prime contractor, Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and instruments. The contract does not have a set-aside designation and has an ultimate...
This federal contract award, valued at $24,440.00, was issued by the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment. The contract is for the delivery of 10 boxes of 48-well Axion CytoView microelectrode array (MEA) plates, which are required for neurotoxicity screening assays as part of the HEAL siRNA/ASO toxicity collaborative...
This contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of biomedical research equipment and instruments. The $728,050 firm fixed-price purchase order is for the provision of Maestro Apex system, Maestro Pro microelectrode array (MEA) platform, and related accessories to support NCATS' Helping to End Addiction Long Term (HEAL) Initiative. The equipment...
This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...
This is a $216,245 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for a Multiwell Microelectrode Array System, which is a specialized laboratory instrument used for real-time monitoring of neural and cardiac activity. The prime contractor is Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of biomedical research equipment. This contract...
This is a $12,500 firm fixed-price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian federal agency, to Axion Biosystems, Inc., a foreign-owned manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of an optical stimulation system, which is likely to support NIAAA's biomedical research initiatives involving the real-time monitoring of neural and cardiac activity. Axion Biosystems has a strong...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $203,800.00 firm fixed-price purchase order to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer, for the Maestro Pro microelectrode array (MEA) system and related support services. This non-competitive acquisition was conducted under FAR Simplified Acquisition Procedures for commercial items to support the Stem Cell Translation Laboratory (SCTL) within the...

This is a $669,000.00 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Axion Biosystems, Inc. for a service agreement to provide preventative maintenance, repairs, updates, and loaner units for multiple Axion Biosystems microelectrode array instruments and liquid handling robot components located at NCATS' facility in Rockville, Maryland. The base period of performance is 12 months starting September 12, 2023. This non-competitive acquisition is being conducted under simplified commercial item procedures since it requires services specific to Axion Biosystems brand equipment. There is no set-aside designation for this requirement.

Generated 1/14/25, 9:11 AM